Exact Mass: 303.1470506

Exact Mass Matches: 303.1470506

Found 500 metabolites which its exact mass value is equals to given mass value 303.1470506, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Evodiamine

(1S)-21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,15,17,19-HEPTAEN-14-ONE

C19H17N3O (303.1371552)


Evodiamine is a member of beta-carbolines. Evodiamine is a natural product found in Vepris soyauxii, Cryptocarya, and other organisms with data available. Origin: Plant; Formula(Parent): C19H17N3O; Bottle Name:Evodiamine; PRIME Parent Name:Evodiamine; PRIME in-house No.:V0296; SubCategory_DNP: Monoterpenoid indole alkaloids, Indoloquinolizidine alkaloids, Indole alkaloids Formula(Parent): C19H17N3O; Bottle Name:Evodiamine; Origin: Plant; PRIME Parent Name:Evodiamine; PRIME in-house No.:V0296; SubCategory_DNP: Monoterpenoid indole alkaloids, Indoloquinolizidine alkaloids, Indole alkaloids Annotation level-1 (±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1]. Evodiamine is an alkaloid isolated from the fruit of Evodia rutaecarpa Bentham with diverse biological activities including anti-inflammatory, anti-obesity, and antitumor. Evodiamine is an alkaloid isolated from the fruit of Evodia rutaecarpa Bentham with diverse biological activities including anti-inflammatory, anti-obesity, and antitumor.

   

Scopolamine

(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1470506)


Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is part of the secondary metabolites of plants. Scopolamine is used criminally as a date rape drug and as an aid to robbery, the most common act being the clandestine drugging of a victims drink. It is preferred because it induces retrograde amnesia, or an inability to recall events prior to its administration. Victims of this crime are often admitted to a hospital in police custody, under the assumption that the patient is experiencing a psychotic episode. A telltale sign is a fever accompanied by a lack of sweat. An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is part of the secondary metabolites of plants. A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents KEIO_ID S040; [MS2] KO009233 KEIO_ID S040

   

Cocaine

[1R-(exo,exo)]-3-(Benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester

C17H21NO4 (303.1470506)


Cocaine, also known as coke, is an alkaloid ester obtained from the leaves of the coca plant (PMID: 20857618). It is a weakly alkaline compound and can therefore combine with acidic compounds to form white salts or powders (which is how it is typically sold and consumed). Cocaine is a strong stimulant that is most frequently used as a recreational drug. It is the second most frequently used illegal drug globally, after cannabis. The stimulant and hunger suppression properties of cocaine and coca leaf extracts have been known for thousands of years by indigenous groups in central and South America. The coca leaf was, and still is, chewed almost universally by some indigenous communities. Cocaine acts by inhibiting the reuptake of serotonin, norepinephrine, and dopamine. This inhibition leads to a number of mental and physical effects that may include loss of contact with reality, an intense feeling of happiness, periods of agitation, along with a rapid heart rate, sweating, and dialated pupils. Cocaine is highly addictive due to its effect on the reward pathway in the brain (PMID: 22856655). Cocaine addiction occurs through overexpression of the FosB protein in the nucleus accumbens of the brain, which results in altered transcriptional regulation in neurons within the nucleus accumbens. Cocaine is harmful. Its use increases the risk of stroke, myocardial infarction, lung problems (in those who smoke it), blood infections, and sudden cardiac death. Medically, cocaine is infrequently used as a local anesthetic and vasoconstrictor to cause loss of feeling or numbness before certain medical procedures (e.g., biopsy, stitches, wound cleaning) (PMID: 28956316). Topical cocaine is occasionally used as a local numbing agent to help with painful procedures in the mouth or nose. Cocaine is now predominantly used for nasal and lacrimal duct surgery. It works quickly to numb certain areas of the body (e.g., nose, ear, or throat) about 1-2 minutes after application. Cocaine functions as an anesthesia by reversibly binding to and inactivating sodium channels, thereby inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. Cocaine and its major metabolites are only found in individuals that have used or taken this drug. D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AD - Anesthetics, local S - Sensory organs > S02 - Otologicals > S02D - Other otologicals > S02DA - Analgesics and anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BC - Esters of benzoic acid S - Sensory organs > S01 - Ophthalmologicals > S01H - Local anesthetics > S01HA - Local anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2817 EAWAG_UCHEM_ID 2817; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1619 D049990 - Membrane Transport Modulators

   

Fenamiphos

Ethyl 3-methyl-4-(methylsulphanyl)phenyl (1-methylethyl)amidophosphoric acid

C13H22NO3PS (303.10579520000005)


CONFIDENCE standard compound; INTERNAL_ID 1097; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9512; ORIGINAL_PRECURSOR_SCAN_NO 9511 CONFIDENCE standard compound; INTERNAL_ID 1097; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9468; ORIGINAL_PRECURSOR_SCAN_NO 9467 CONFIDENCE standard compound; INTERNAL_ID 1097; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9521; ORIGINAL_PRECURSOR_SCAN_NO 9519 CONFIDENCE standard compound; INTERNAL_ID 1097; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9503; ORIGINAL_PRECURSOR_SCAN_NO 9502 CONFIDENCE standard compound; INTERNAL_ID 1097; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9453; ORIGINAL_PRECURSOR_SCAN_NO 9452 CONFIDENCE standard compound; INTERNAL_ID 1097; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9474; ORIGINAL_PRECURSOR_SCAN_NO 9473 Systemic agricultural nematocide. Cholinesterase inhibitor Fenamiphos is an organophosphate acetylcholinesterase inhibitor used as an insecticide C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D016573 - Agrochemicals D010575 - Pesticides

   

Nicotianamine

(S,S,S)-nicotianamine

C12H21N3O6 (303.1430286)


The (S,S,S)-stereoisomer of nicotianamine. IPB_RECORD: 2921; CONFIDENCE confident structure

   

Phenoxybenzamine

Wellspring brand OF phenoxybenzamine hydrochloride

C18H22ClNO (303.13898320000004)


Phenoxybenzamine is only found in individuals that have used or taken this drug. It is an alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. [PubChem]Phenoxybenzamine produces its therapeutic actions by blocking alpha receptors, leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure. C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

SCHEMBL4290912

N(6)-[(indol-3-yl)acetyl]-L-lysine

C16H21N3O3 (303.1582836)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   
   

Habranthine

11alpha-hydroxygalanthamine

C17H21NO4 (303.1470506)


   

Retigabine

Ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride

C16H18FN3O2 (303.138298)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators Same as: D09569

   

alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol

alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol

C21H21NO (303.1623056)


   

11-Deoxytetrodotoxin

11-Deoxytetrodotoxin

C11H17N3O7 (303.1066452)


D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

   

Chlorphenoxamine

Chlorphenoxamine

C18H22ClNO (303.13898320000004)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent. Target: Histamine Receptor

   

Pipemidic acid

5,8-Dihydro-8-ethyl-5-oxo-2-(1-piperazinyl)pyrido(2,3-D)pyrimidine-6-carboxylic acid

C14H17N5O3 (303.1331332)


Pipemidic acid is a member of the pyridopyrimidine class of antibacterials, which display some overlap in mechanism of action with analogous pyridone-containing quinolones. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

   

beta-oxymorphol

(1S,5R,13R,14R,17S)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-10,14,17-triol

C17H21NO4 (303.1470506)


beta-oxymorphol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

Fenoterol

1-(p-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3,5-dihydroxyphenyl))ethyl)aminopropane

C17H21NO4 (303.1470506)


Fenoterol is only found in individuals that have used or taken this drug. It is an adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. [PubChem]Beta(2)-receptor stimulation by fenoterol in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Fenoterol (Th-1165), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research[1][2].

   

gamma-Glutamylarginine

(2S)-2-{[(4S)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-carbamimidamidopentanoate

C11H21N5O5 (303.15426160000004)


gamma-Glutamylarginine is a dipeptide composed of gamma-glutamate and arginine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamylarginine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

2-Amino-4-({1-carboxy-4-[(1-hydroxyethylidene)amino]butyl}-C-hydroxycarbonimidoyl)butanoate

C12H21N3O6 (303.1430286)


N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is found in pulses. N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is a constituent of the seeds of green gram (Vigna radiata). Constituent of the seeds of green gram (Vigna radiata). N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is found in pulses.

   

Valyltryptophan

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3 (303.1582836)


Valyltryptophan is a dipeptide composed of valine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor Dipeptide 2 (N-Valyltryptophan; Val-Trp) is a bioactive peptide with anti-aging effect and has been reported used as a cosmetic ingredient[1].

   

Tryptophyl-Valine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-methylbutanoate

C16H21N3O3 (303.1582836)


Tryptophyl-Valine is a dipeptide composed of tryptophan and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Glutamylarginine

(2S)-2-{[(2S)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-5-carbamimidamidopentanoate

C11H21N5O5 (303.15426160000004)


Glutamylarginine is a dipeptide composed of glutamate and arginine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylarginine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Arginylglutamic acid

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]pentanedioic acid

C11H21N5O5 (303.15426160000004)


Arginylglutamic acid is a dipeptide composed of arginine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Indoleacetyl glutamine

4-carbamoyl-2-[2-(1H-indol-3-yl)acetamido]butanoic acid

C15H17N3O4 (303.1219002)


Indoleacetyl glutamine is indolic derivative of tryptophan. It is generated from indoleacetic acid. Indoleacetic acid (IAA) is a breakdown product of tryptophan metabolism and is often produced by the action of bacteria in the mammalian gut. Some endogenous production of IAA in mammalian tissues also occurs. It may be produced by the decarboxylation of tryptamine or the oxidative deamination of tryptophan. Indoleacetyl glutamine frequently occurs at low levels in urine and has been found in elevated levels in the urine of patients with hartnup disease, the characteristic symptoms of the disease are mental retardation and pellagra like skin rash. [HMDB] Indoleacetyl glutamine is indolic derivative of tryptophan. It is generated from indoleacetic acid. Indoleacetic acid (IAA) is a breakdown product of tryptophan metabolism and is often produced by the action of bacteria in the mammalian gut. Some endogenous production of IAA in mammalian tissues also occurs. It may be produced by the decarboxylation of tryptamine or the oxidative deamination of tryptophan. Indoleacetyl glutamine frequently occurs at low levels in urine and has been found in elevated levels in the urine of patients with hartnup disease, the characteristic symptoms of the disease are mental retardation and pellagra like skin rash.

   

Pimelylcarnitine

(3R)-3-[(6-carboxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.168179)


Pimelylcarnitine is an acylcarnitine. More specifically, it is an pimelic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Pimelylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine pimelylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyetodolac

2-{1,8-diethyl-6-hydroxy-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid

C17H21NO4 (303.1470506)


6-Hydroxyetodolac is a metabolite of Etodolac, a novel antiinflammatory agent. Metabolites of Etodolac include etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid) are described, viz. 6-hydroxyetodolac, N-methyletodolac, 4-ureidoetodolac, 8-(1-hydroxy)etodolac, and 4-oxoetodolac. (PMID: 2970548)

   

7-Hydroxyetodolac

2-{1,8-diethyl-7-hydroxy-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid

C17H21NO4 (303.1470506)


7-Hydroxyetodolac is a metabolite of Etodolac. Phase I metabolites of Etodolac are 6-hydroxy etodolac (6-OH-ET), 7-hydroxy etodolac (7-OH-ET) and 8-(1-hydroxyethyl) etodolac (8-OH-ET). (PMID: 10961329)

   

alpha-noroxycodol

(1S,5R,13R,14S,17S)-10-methoxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-14,17-diol

C17H21NO4 (303.1470506)


alpha-noroxycodol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

beta-noroxycodol

(1S,13R,14R,17S)-10-methoxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-14,17-diol

C17H21NO4 (303.1470506)


beta-noroxycodol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

Chlorphenoxamine

{2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl}dimethylamine

C18H22ClNO (303.13898320000004)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chlorphenoxamine is a first-generation ethanolamine H1-antihistamine. Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent. Target: Histamine Receptor

   

2,2-dimethylpentanedioylcarnitine

3-[(4-carboxy-4,4-dimethylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.168179)


2,2-dimethylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an 2,2-dimethylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2,2-dimethylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2,2-dimethylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-4-Hydroxy-3-methylpent-2-enedioylcarnitine

3-[(4-carboxy-2-hydroxy-3-methylbut-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H21NO7 (303.13179560000003)


(2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-4-hydroxy-3-methylpent-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine (2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular (2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is elevated in the blood or plasma of individuals with 3-hydroxy-3-ethylglutarylCoA lyase deficiency (PMID: 32685354). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethylpentanedioylcarnitine

3-[(4-carboxy-4-ethylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.168179)


2-Ethylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Lauroyl Cysteine

2-dodecanamido-3-sulfanylpropanoic acid

C15H29NO3S (303.1868044)


N-lauroyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

O-Pimeloylcarnitine

4-[(6-Carboxyhexanoyl)oxy]-4-(trimethylammonio)butanoic acid

C14H25NO6 (303.168179)


   

(1-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulfonate

(1-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulphonic acid

C12H21N3O4S (303.1252706)


   

5-Pyrimidinecarboxylic acid, 1,4-dihydro-2-((2-(2-methylpropoxy)phenyl)amino)-4-oxo-

5-Pyrimidinecarboxylic acid, 1,4-dihydro-2-((2-(2-methylpropoxy)phenyl)amino)-4-oxo-

C15H17N3O4 (303.1219002)


   

[(1S,2S,4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

[(1S,2S,4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoic acid

C17H21NO4 (303.1470506)


   

(+)-Cocaine

Methyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C17H21NO4 (303.1470506)


   

4-(1-Hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,2-diol

4-(1-Hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,2-diol

C17H21NO4 (303.1470506)


   

3-(2-Chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine

3-(2-Chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine

C18H22ClNO (303.13898320000004)


   

Aditoprim

5-{[4-(dimethylamino)-3,5-dimethoxyphenyl]methyl}pyrimidine-2,4-diamine

C15H21N5O2 (303.1695166)


   

Aptiganel

N-(3-ethylphenyl)-N-methyl-N-(naphthalen-1-yl)guanidine

C20H21N3 (303.17353860000003)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   

Evodiamine

21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

C19H17N3O (303.1371552)


(±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1].

   

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

C12H21N3O6 (303.1430286)


   

1-Oxononan-4-yl (2R)-2-acetamido-3-sulfanylpropanoate

N-{1-oxo-1-[(1-oxononan-4-yl)oxy]-3-sulphanylpropan-2-yl}ethanimidic acid

C14H25NO4S (303.15042100000005)


   

Norcocaethylene

Ethyl 3-(benzoyloxy)-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C17H21NO4 (303.1470506)


   

NOTA

2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid

C12H21N3O6 (303.1430286)


   

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-methoxy-2-phenylpropanoate

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-methoxy-2-phenylpropanoic acid

C18H25NO3 (303.18343400000003)


   

Zolmitriptan N-Oxide

N,N-dimethyl-2-{5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide

C16H21N3O3 (303.1582836)


   

N2-gamma-L-Glutamyl-L-arginine

2-amino-4-[(4-carbamimidamido-1-carboxybutyl)carbamoyl]butanoic acid

C11H21N5O5 (303.15426160000004)


Constituent of Allium cepa (onion), Panax ginseng (ginseng). After intravenous administration of DTIC-Dome, the volume of distribution exceeds total body water content suggesting localization in some body tissue, probably the liver. Its disappearance from the plasma is biphasic with initial half-life of 19 minutes and a terminal half-life of 5 hours. 1 In a patient with renal and hepatic dysfunctions, the half-lives were lengthened to 55 minutes and 7.2 hours. 1 The average cumulative excretion of unchanged DTIC in the urine is 40\\% of the injected dose in 6 hours. 1 DTIC is subject to renal tubular secretion rather than glomerular filtration. At therapeutic concentrations DTIC is not appreciably bound to human plasma protein. N2-gamma-L-Glutamyl-L-arginine is found in garden onion, tea, and onion-family vegetables. Constituent of Allium cepa (onion), Panax ginseng (ginseng)

   

Scopolamine

BENZENEACETIC ACID, .ALPHA.(HYDROXYMETHYL)-,(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (.ALPHA.S)-

C17H21NO4 (303.1470506)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Scopolamine hydrobromide appears as colorless crystals or white powder or solid. Has no odor. pH (of 5\\% solution): 4-5.5. Slightly efflorescent in dry air. Bitter, acrid taste. (NTP, 1992) Scopolamine is a tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol. It has a role as a muscarinic antagonist, an antiemetic, an adjuvant, a mydriatic agent, an antispasmodic drug, an anaesthesia adjuvant, an antidepressant and a metabolite. It is a propanoate ester, an epoxide, a tertiary amino compound and a tropane alkaloid. It is functionally related to a (S)-tropic acid. It is a conjugate base of a scopolamine(1+). Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to [atropine] and [hyoscyamine], all of which structurally mimic the natural neurotransmitter [acetylcholine]. Scopolamine was first synthesized in 1959, but to date, synthesis remains less efficient than extracting scopolamine from plants. As an acetylcholine analogue, scopolamine can antagonize muscarinic acetylcholine receptors (mAChRs) in the central nervous system and throughout the body, inducing several therapeutic and adverse effects related to alteration of parasympathetic nervous system and cholinergic signalling. Due to its dose-dependent adverse effects, scopolamine was the first drug to be offered commercially as a transdermal delivery system, Scopoderm TTS®, in 1981. As a result of its anticholinergic effects, scopolamine is being investigated for diverse therapeutic applications; currently, it is approved for the prevention of nausea and vomiting associated with motion sickness and surgical procedures. Scopolamine was first approved by the FDA on December 31, 1979, and is currently available as both oral tablets and a transdermal delivery system. Scopolamine is an Anticholinergic. The mechanism of action of scopolamine is as a Cholinergic Antagonist. Hyoscine is a natural product found in Duboisia leichhardtii, Duboisia myoporoides, and other organisms with data available. Scopolamine is a tropane alkaloid derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties. Structurally similar to acetylcholine, scopolamine antagonizes acetylcholine activity mediated by muscarinic receptors located on structures innervated by postganglionic cholinergic nerves as well as on smooth muscles that respond to acetylcholine but lack cholinergic innervation. The agent is used to cause mydriasis, cycloplegia, to control the secretion of saliva and gastric acid, to slow gut motility, and prevent vomiting. An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic. A tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5225; ORIGINAL_PRECURSOR_SCAN_NO 5222 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5230; ORIGINAL_PRECURSOR_SCAN_NO 5228 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5252; ORIGINAL_PRECURSOR_SCAN_NO 5251 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5243; ORIGINAL_PRECURSOR_SCAN_NO 5241 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5254; ORIGINAL_PRECURSOR_SCAN_NO 5252 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2318 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.290 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.274 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.276

   
   
   
   
   
   

4-Desmethylpiplartine

4-Desmethylpiplartine

C16H17NO5 (303.1106672)


   
   

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1H-pyrrole-2-carboxamide

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1H-pyrrole-2-carboxamide

C13H17N7O2 (303.1443662)


   
   
   

11alpha-hydroxygalanthamine

11alpha-hydroxygalanthamine

C17H21NO4 (303.1470506)


   
   
   
   

N-Demethyllunidonine

N-Demethyllunidonine

C16H17NO5 (303.1106672)


   
   
   
   
   
   
   
   
   

1-(1-oxo-3-phenylpropyl)-3alpha,4alpha-epoxy-5beta-acetyloxy-2-piperidone|3alpha,4alpha-epoxy-5beta-pipermethystine

1-(1-oxo-3-phenylpropyl)-3alpha,4alpha-epoxy-5beta-acetyloxy-2-piperidone|3alpha,4alpha-epoxy-5beta-pipermethystine

C16H17NO5 (303.1106672)


   

(+-)-N-Methyloreolin|(??)-Oridine|N-Methyl-oreolin|N-Methyl-oridin|N-Methyloreolin

(+-)-N-Methyloreolin|(??)-Oridine|N-Methyl-oreolin|N-Methyl-oridin|N-Methyloreolin

C18H25NO3 (303.18343400000003)


   
   
   
   
   

O7-Me-4-(5,7-Dihydroyxy-2-methyl-6-chromanyl)-2-piperidone

O7-Me-4-(5,7-Dihydroyxy-2-methyl-6-chromanyl)-2-piperidone

C16H17NO5 (303.1106672)


   

(+/-)-neohydroxylunine

(+/-)-neohydroxylunine

C16H17NO5 (303.1106672)


   

Methyl 2,3-di-O-acetyl-4-(acetylamino)-4,6-dideoxyhexopyranoside #

Methyl 2,3-di-O-acetyl-4-(acetylamino)-4,6-dideoxyhexopyranoside #

C13H21NO7 (303.13179560000003)


   

(+)-mostueine|Mostueine.|mostuenine

(+)-mostueine|Mostueine.|mostuenine

C20H21N3 (303.17353860000003)


   

6-Methoxy-8-(1-hydroxy-1-methylethyl)-7,8-dihydro-1,3-dioxolo[4,5-h]furo[2,3-b]quinoline

6-Methoxy-8-(1-hydroxy-1-methylethyl)-7,8-dihydro-1,3-dioxolo[4,5-h]furo[2,3-b]quinoline

C16H17NO5 (303.1106672)


   

(2R,2S)-3-(2,3-Dihydroxy-3-methylbutyl)-5-(2,3-epoxy-3-methylbutyl)indole

(2R,2S)-3-(2,3-Dihydroxy-3-methylbutyl)-5-(2,3-epoxy-3-methylbutyl)indole

C18H25NO3 (303.18343400000003)


   

(E)-N-methyl-N-(1-naphthylmethyl)-3-(4-hydroxyphenyl)-2-propen-1-amine

(E)-N-methyl-N-(1-naphthylmethyl)-3-(4-hydroxyphenyl)-2-propen-1-amine

C21H21NO (303.1623056)


   
   

(-)-suaveoline|(6S,13S)-4-ethyl-6,7,12,13-tetrahydro-7-methyl-6,13-imino-5H-pyrido[3,4:5,6]cyclooct[1,2-b]indole|4-ethyl-7-methyl-6,7,12,13-tetrahydro-5H-6,13-epiazano-pyrido[3,4:5,6]cycloocta[1,2-b]indole|Suaveolin|suaveoline|Suaveoline +

(-)-suaveoline|(6S,13S)-4-ethyl-6,7,12,13-tetrahydro-7-methyl-6,13-imino-5H-pyrido[3,4:5,6]cyclooct[1,2-b]indole|4-ethyl-7-methyl-6,7,12,13-tetrahydro-5H-6,13-epiazano-pyrido[3,4:5,6]cycloocta[1,2-b]indole|Suaveolin|suaveoline|Suaveoline +

C20H21N3 (303.17353860000003)


   

Me glycoside,N-Ac,2,4-di-O Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

Me glycoside,N-Ac,2,4-di-O Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

C13H21NO7 (303.13179560000003)


   
   
   

(-)-berkeleyamide A|(10S,11R,14S)-berkeleyamide A|berkeleyamide A

(-)-berkeleyamide A|(10S,11R,14S)-berkeleyamide A|berkeleyamide A

C18H25NO3 (303.18343400000003)


   

9,10-Dimethoxy-3,12-didehydrogalanthan-1,2-diol #

9,10-Dimethoxy-3,12-didehydrogalanthan-1,2-diol #

C17H21NO4 (303.1470506)


   
   

8-oxo-alpha-erythroidine epoxide

8-oxo-alpha-erythroidine epoxide

C16H17NO5 (303.1106672)


   

3-Cinnamoyloxy-6,7-tropanediol

3-Cinnamoyloxy-6,7-tropanediol

C17H21NO4 (303.1470506)


   

2-[(3-isopropoy-O-beta-D-glucopyranosyl)oxy]-2-methylbutanenitrile

2-[(3-isopropoy-O-beta-D-glucopyranosyl)oxy]-2-methylbutanenitrile

C14H25NO6 (303.168179)


   

2R-hydroxy-O,N-dimethylnorbelladine

2R-hydroxy-O,N-dimethylnorbelladine

C17H21NO4 (303.1470506)


   
   

(-)-8-(alpha-Hydroxy-isopropyl)-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]chinolin-6-on|(-)-8-(alpha-hydroxy-isopropyl)-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]quinolin-6-one|8-(1-hydroxy-1-methyl-ethyl)-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]quinolin-6-one|Hydroxylunin|hydroxylunine

(-)-8-(alpha-Hydroxy-isopropyl)-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]chinolin-6-on|(-)-8-(alpha-hydroxy-isopropyl)-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]quinolin-6-one|8-(1-hydroxy-1-methyl-ethyl)-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]quinolin-6-one|Hydroxylunin|hydroxylunine

C16H17NO5 (303.1106672)


   
   
   

(1alpha,2beta)-1,2-dihydroxy-9,10-[methylenebis(oxy)]galanthan-7-one|1alpha,2beta-dihydroxy-9,10-methanediyldioxy-galanthan-7-one|1alpha,2beta-dihydroxy-9,10-methylenedioxy-galanthan-7-one|7-oxodihydrolycorine|alpha-dihydro-lycorine-lactam|alpha-dihydrolycorine lactam|alpha-dihydrolycorinelactam

(1alpha,2beta)-1,2-dihydroxy-9,10-[methylenebis(oxy)]galanthan-7-one|1alpha,2beta-dihydroxy-9,10-methanediyldioxy-galanthan-7-one|1alpha,2beta-dihydroxy-9,10-methylenedioxy-galanthan-7-one|7-oxodihydrolycorine|alpha-dihydro-lycorine-lactam|alpha-dihydrolycorine lactam|alpha-dihydrolycorinelactam

C16H17NO5 (303.1106672)


   
   
   
   

(13bS)-8,13,13b,14-tetrahydro-1-methylindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridin-5(7H)-one|Latifoliamide D

(13bS)-8,13,13b,14-tetrahydro-1-methylindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridin-5(7H)-one|Latifoliamide D

C19H17N3O (303.1371552)


   

(7aS,10R,11aR)-7a,8,9,10,11,11a-hexahydro-5,10-dihydroxy-2,8-dimethyl-4H-pyrano[2?,3?:4,5]benzofuro[2,3-b]pyridin-4-one|chrotacumine E

(7aS,10R,11aR)-7a,8,9,10,11,11a-hexahydro-5,10-dihydroxy-2,8-dimethyl-4H-pyrano[2?,3?:4,5]benzofuro[2,3-b]pyridin-4-one|chrotacumine E

C16H17NO5 (303.1106672)


   

(-)-3-methoxy-4-O-methyljoubertiamine|(S)-3-Methoxy-4-O-methyljoubertiamine|O-methyljoubertiamine

(-)-3-methoxy-4-O-methyljoubertiamine|(S)-3-Methoxy-4-O-methyljoubertiamine|O-methyljoubertiamine

C18H25NO3 (303.18343400000003)


   
   

4-(5,7-dihydroxy-2-methyl-4-oxo-4H-chromen-6-yl)-1-methyl-piperidin-2-one|N-Me-4-(5,7-Dihydroyxy-2-methyl-6-chromanyl)-2-piperidone

4-(5,7-dihydroxy-2-methyl-4-oxo-4H-chromen-6-yl)-1-methyl-piperidin-2-one|N-Me-4-(5,7-Dihydroyxy-2-methyl-6-chromanyl)-2-piperidone

C16H17NO5 (303.1106672)


   

(2E)-N-isobutyl-7-(3,4-methylenedioxy)phenylheptenenamide|(2E)-N-isobutyl-7-(3,4-methylenedioxyphenyl)hepta-2-enamide|Pipercallosidine

(2E)-N-isobutyl-7-(3,4-methylenedioxy)phenylheptenenamide|(2E)-N-isobutyl-7-(3,4-methylenedioxyphenyl)hepta-2-enamide|Pipercallosidine

C18H25NO3 (303.18343400000003)


   

10-O-demethylproemethine|10-O-demethylprotoemetine

10-O-demethylproemethine|10-O-demethylprotoemetine

C18H25NO3 (303.18343400000003)


   

(6R)-3alpha-benzoyloxy-6beta-acetoxytropane|6beta-acetoxy-3alpha-benzoyloxytropane

(6R)-3alpha-benzoyloxy-6beta-acetoxytropane|6beta-acetoxy-3alpha-benzoyloxytropane

C17H21NO4 (303.1470506)


   

Dihydro-desmethoxyambelline

Dihydro-desmethoxyambelline

C17H21NO4 (303.1470506)


   

1-hydroxy-5,11-dideoxytetrodotoxin

1-hydroxy-5,11-dideoxytetrodotoxin

C11H17N3O7 (303.1066452)


   

3,4-dihydro-5,8,9-trimethoxy-2,2-dimethyl-2h-pyrano[2,3-b]quinoline

3,4-dihydro-5,8,9-trimethoxy-2,2-dimethyl-2h-pyrano[2,3-b]quinoline

C17H21NO4 (303.1470506)


   

3-hydroxy-3-nonyl-1H-quinoline-2,4-dione

3-hydroxy-3-nonyl-1H-quinoline-2,4-dione

C18H25NO3 (303.18343400000003)


   

6-methoxy-9,9-dimethyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h]pyrano[2,3-b]quinolin-8-ol|Pteleflorin|Pteleflorine

6-methoxy-9,9-dimethyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h]pyrano[2,3-b]quinolin-8-ol|Pteleflorin|Pteleflorine

C16H17NO5 (303.1106672)


   

Dihydroepinatalensine

Dihydroepinatalensine

C17H21NO4 (303.1470506)


   

(E)-N-methyl-N-(1-naphthylmethyl)-3-(3-hydroxyphenyl)-2-propen-1-amine

(E)-N-methyl-N-(1-naphthylmethyl)-3-(3-hydroxyphenyl)-2-propen-1-amine

C21H21NO (303.1623056)


   

N-Methylpreskimmianine

N-Methylpreskimmianine

C17H21NO4 (303.1470506)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Tribenzylamine N-oxide

Tribenzylamine N-oxide

C21H21NO (303.1623056)


   
   
   
   
   
   
   

(±)-Evodiamine

(+/-)-Evodiamine

C19H17N3O (303.1371552)


(±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1].

   
   

Galantamine N-Oxide

6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, 11-OXIDE, (4AS-(4A.ALPHA.,6.BETA.,8AR*))-

C17H21NO4 (303.1470506)


Galanthamine N-Oxide is a natural product found in Lycoris sanguinea, Lycoris radiata, and Lycoris incarnata with data available. Galanthamine N-Oxide is an alkaloid obtained from the bulbs of Zephyranthes concolor. Galanthamine N-Oxide inhibits electric eel acetylcholinesterase (AChE) with an EC50 of 26.2 μM. Galanthamine N-Oxide is a prominent inhibitor of substrate accommodation in the active site of the Torpedo californica AChE (TcAChE), hAChE and hBChE enzymes[1][2].

   

Pipemidic acid

Pipemidic acid

C14H17N5O3 (303.1331332)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3075

   

phenoxybenzamine

phenoxybenzamine

C18H22ClNO (303.13898320000004)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents KEIO_ID P206; [MS2] KO009176 KEIO_ID P206

   

fenoterol

fenoterol

C17H21NO4 (303.1470506)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Fenoterol (Th-1165), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research[1][2].

   

Transcop

Scopolamine hydrobromide

C17H21NO4 (303.1470506)


   
   

C18H25NO3_2-Heptenamide, 7-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)-, (2E)

NCGC00347573-02_C18H25NO3_2-Heptenamide, 7-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)-, (2E)-

C18H25NO3 (303.18343400000003)


   

cocaine

cocaine

C17H21NO4 (303.1470506)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AD - Anesthetics, local S - Sensory organs > S02 - Otologicals > S02D - Other otologicals > S02DA - Analgesics and anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BC - Esters of benzoic acid S - Sensory organs > S01 - Ophthalmologicals > S01H - Local anesthetics > S01HA - Local anesthetics A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Atroscine

[(4R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] 3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1470506)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids

   

tetra(methoxymethyl)melamine (putative)

tetra(methoxymethyl)melamine (putative)

[C11H23N6O4]+ (303.1780698)


   

4-O,N-dimethylnorbelladine-N-oxide

4-O,N-dimethylnorbelladine-N-oxide

C17H21NO4 (303.1470506)


   
   

Gly Gly Gly Asn

(2S)-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}-3-carbamoylpropanoic acid

C10H17N5O6 (303.1178782)


   

Gly Gly Asn Gly

2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]acetic acid

C10H17N5O6 (303.1178782)


   

Gly Asn Gly Gly

2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}acetic acid

C10H17N5O6 (303.1178782)


   
   
   
   
   
   
   
   
   
   
   
   

Asn Gly Gly Gly

2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)acetic acid

C10H17N5O6 (303.1178782)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Val Trp

Dipeptide-2

C16H21N3O3 (303.1582836)


Dipeptide 2 (N-Valyltryptophan; Val-Trp) is a bioactive peptide with anti-aging effect and has been reported used as a cosmetic ingredient[1].

   
   
   
   

8-(1-Hydroxyethyl)etodolac

8-(1-Hydroxyethyl)etodolac

C17H21NO4 (303.1470506)


   
   
   
   

TRP-Val

2-(2-amino-3-methylbutanamido)-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3 (303.1582836)


A dipeptide formed from L-tryptophan and L-valine residues.

   

Val-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C16H21N3O3 (303.1582836)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor Dipeptide 2 (N-Valyltryptophan; Val-Trp) is a bioactive peptide with anti-aging effect and has been reported used as a cosmetic ingredient[1].

   

N5-Acetyl-N2-g-glutamylornithine, 9ci

2-amino-4-[(1-carboxy-4-acetamidobutyl)carbamoyl]butanoic acid

C12H21N3O6 (303.1430286)


   

Auramine O

Auramine O

C17H22ClN3 (303.15021620000005)


D000890 - Anti-Infective Agents D004396 - Coloring Agents D004202 - Disinfectants

   

(2E)-N-(2,4-DIMETHYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE

(2E)-N-(2,4-DIMETHYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE

C21H21NO (303.1623056)


   

3-(4-ETHOXY-PHENYL)-3-[(FURAN-2-CARBONYL)-AMINO]-PROPIONIC ACID

3-(4-ETHOXY-PHENYL)-3-[(FURAN-2-CARBONYL)-AMINO]-PROPIONIC ACID

C16H17NO5 (303.1106672)


   

(R)-2-AMINO-1,1,3-TRIPHENYLPROPAN-1-OL

(R)-2-AMINO-1,1,3-TRIPHENYLPROPAN-1-OL

C21H21NO (303.1623056)


   

methyl 5,5,5-trifluoro-4-(4-methoxy-2-methylphenyl)iminopentanoate

methyl 5,5,5-trifluoro-4-(4-methoxy-2-methylphenyl)iminopentanoate

C14H16F3NO3 (303.1082222)


   

ethyltris(2-hydroxyethyl)ammonium ethyl sulphate

ethyltris(2-hydroxyethyl)ammonium ethyl sulphate

C10H25NO7S (303.135166)


   

2-Acetamido-2-deoxy-4,6-O-isopropylidene-D-glucopyranose

2-Acetamido-2-deoxy-4,6-O-isopropylidene-D-glucopyranose

C13H21NO7 (303.13179560000003)


   

2-Methoxy-3-(trifluoromethyl)pyridine-5-boronic acid pinacol ester

2-Methoxy-3-(trifluoromethyl)pyridine-5-boronic acid pinacol ester

C13H17BF3NO3 (303.12535180000003)


   

Hydromorphinol

Hydromorphinol

C17H21NO4 (303.1470506)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

Boc-D-Glu(OtBu)-OH

Boc-D-Glu(OtBu)-OH

C14H25NO6 (303.168179)


   

Uracil,6-amino-5-(2-anilinoacetamido)-1,3-dimethyl- (5CI)

Uracil,6-amino-5-(2-anilinoacetamido)-1,3-dimethyl- (5CI)

C14H17N5O3 (303.1331332)


   

tert-butyl 3-(2-ethoxy-2-oxoethyl)indole-1-carboxylate

tert-butyl 3-(2-ethoxy-2-oxoethyl)indole-1-carboxylate

C17H21NO4 (303.1470506)


   

4-tert-butyl-N-(4-methylphenyl)benzenesulfonamide

4-tert-butyl-N-(4-methylphenyl)benzenesulfonamide

C17H21NO2S (303.12929260000004)


   

N,N-dibutyl-4-chlorobenzenesulfonamide

N,N-dibutyl-4-chlorobenzenesulfonamide

C14H22ClNO2S (303.1059702)


   

3-azido-2 3-dideoxy-1-o-(t-butyldimethy&

3-azido-2 3-dideoxy-1-o-(t-butyldimethy&

C12H25N3O4Si (303.161425)


   

ETHYL 2-(N-CBZ-PIPERIDIN-4-YLIDENE)ACETATE

ETHYL 2-(N-CBZ-PIPERIDIN-4-YLIDENE)ACETATE

C17H21NO4 (303.1470506)


   

TERT-BUTYL SPIRO[ISOCHROMAN-1,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL SPIRO[ISOCHROMAN-1,4-PIPERIDINE]-1-CARBOXYLATE

C18H25NO3 (303.18343400000003)


   

2,4-bis[(4-aminophenyl)methyl]aniline

2,4-bis[(4-aminophenyl)methyl]aniline

C20H21N3 (303.17353860000003)


   

TERT-BUTYL 2-(2-ETHOXY-2-OXOETHYL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 2-(2-ETHOXY-2-OXOETHYL)-1H-INDOLE-1-CARBOXYLATE

C17H21NO4 (303.1470506)


   

tert-Butyl 3-hydroxyspiro[indan-1,4-piperidine]-1-carboxylate

tert-Butyl 3-hydroxyspiro[indan-1,4-piperidine]-1-carboxylate

C18H25NO3 (303.18343400000003)


   

6-METHOXYQUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER

6-METHOXYQUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER

C16H17NO5 (303.1106672)


   

L-Anserine · nitrate

L-Anserine · nitrate

C10H17N5O6 (303.1178782)


L-Anserine nitrate is an endogenous metabolite.

   

N,N-Dibenzyl-p-anisidine

N,N-Dibenzyl-p-anisidine

C21H21NO (303.1623056)


   

3-(2-METHOXYCARBONYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(2-METHOXYCARBONYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H21NO4 (303.1470506)


   

N-Methyl-3-pyrrolidinyl Cyclopentylmandelate

N-Methyl-3-pyrrolidinyl Cyclopentylmandelate

C18H25NO3 (303.18343400000003)


   

Benzyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate

Benzyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate

C15H17N3O4 (303.1219002)


   

3-Allyl-1-[(benzyloxy)carbonyl]-3-piperidinecarboxylic acid

3-Allyl-1-[(benzyloxy)carbonyl]-3-piperidinecarboxylic acid

C17H21NO4 (303.1470506)


   
   
   

2-((4-Phenylpiperazine-1-yl)methyl)quinoline

2-((4-Phenylpiperazine-1-yl)methyl)quinoline

C20H21N3 (303.17353860000003)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

C16H18FN3O2 (303.138298)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]-

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]-

C16H18FN3O2 (303.138298)


   
   

tert-Butyl 4-(4-methylbenzoyl)piperidine-1-carboxylate

tert-Butyl 4-(4-methylbenzoyl)piperidine-1-carboxylate

C18H25NO3 (303.18343400000003)


   

Ethyl 1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidine-4-carboxylate

Ethyl 1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidine-4-carboxylate

C13H16F3N3O2 (303.1194552)


   

3-(2-CARBOXY-1-METHYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(2-CARBOXY-1-METHYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H21NO4 (303.1470506)


   

tert-butyl 2-(aminomethyl)-3-[4-(trifluoromethyl)phenyl]propanoate

tert-butyl 2-(aminomethyl)-3-[4-(trifluoromethyl)phenyl]propanoate

C15H20F3NO2 (303.14460560000003)


   

2-Methyl-2-propanyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5- carboxylate

2-Methyl-2-propanyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5- carboxylate

C17H21NO4 (303.1470506)


   

tert-Butyl 4-(5H-pyrrolo[3,2-d]pyrimidin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(5H-pyrrolo[3,2-d]pyrimidin-4-yl)piperazine-1-carboxylate

C15H21N5O2 (303.1695166)


   

4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzoic acid

4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzoic acid

C15H17N3O2S (303.1041422)


   

1H-Indole-1-carboxylic acid, 5-acetyl-2-borono-, 1-(1,1-dimethylethyl) ester (9CI)

1H-Indole-1-carboxylic acid, 5-acetyl-2-borono-, 1-(1,1-dimethylethyl) ester (9CI)

C15H18BNO5 (303.1277968)


   

Metadin

Pipradrol hydrochloride

C18H22ClNO (303.13898320000004)


   

Butoxamine hydrochloride

Butoxamine hydrochloride

C15H26ClNO3 (303.1601116)


Butaxamine (Butoxamin) hydrochloride is a specific β2-adrenergic receptor blocker. Butaxamine hydrochloride inhibits the decreases in urine volume in ethanol-anesthetized, water-diuretic rats[1].

   

Pipemidic acid trihydrate

Pipemidic acid trihydrate

C14H17N5O3 (303.1331332)


   

Methyl (8-benzyl-1-oxa-8-azaspiro[4.5]dec-2-yl)acetate

Methyl (8-benzyl-1-oxa-8-azaspiro[4.5]dec-2-yl)acetate

C18H25NO3 (303.18343400000003)


   

Benzyl 2-oxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate

Benzyl 2-oxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate

C17H21NO4 (303.1470506)


   

(bis-tert-butoxycarbonylmethyl-amino)-acetic acid

(bis-tert-butoxycarbonylmethyl-amino)-acetic acid

C14H25NO6 (303.168179)


   

(2S)-2-Amino-1,1,3-triphenyl-1-propanol

(2S)-2-Amino-1,1,3-triphenyl-1-propanol

C21H21NO (303.1623056)


   

5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone

5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone

C15H17N3O4 (303.1219002)


   

1H-pyrazolo[3,4-b]pyridine-5-carbonitrile

1H-pyrazolo[3,4-b]pyridine-5-carbonitrile

C15H17N3O4 (303.1219002)


   

2-[5-[morpholin-4-yl(phenyl)methyl]tetrazol-1-yl]acetic acid

2-[5-[morpholin-4-yl(phenyl)methyl]tetrazol-1-yl]acetic acid

C14H17N5O3 (303.1331332)


   

BENZYL-(4-BENZYLOXYBENZYL)AMINE

BENZYL-(4-BENZYLOXYBENZYL)AMINE

C21H21NO (303.1623056)


   

tert-butyl 3-oxospiro[2-benzofuran-1,4-piperidine]-1-carboxylate

tert-butyl 3-oxospiro[2-benzofuran-1,4-piperidine]-1-carboxylate

C17H21NO4 (303.1470506)


   

7-((1-METHYLPIPERIDIN-4-YL)METHOXY)-6-METHOXYQUINAZOLIN-4(3H)-ONE

7-((1-METHYLPIPERIDIN-4-YL)METHOXY)-6-METHOXYQUINAZOLIN-4(3H)-ONE

C16H21N3O3 (303.1582836)


   

Benzyl 4-(2-oxoimidazolidin-1-yl)piperidine-1-carboxylate

Benzyl 4-(2-oxoimidazolidin-1-yl)piperidine-1-carboxylate

C16H21N3O3 (303.1582836)


   
   

4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4H-pyran

4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4H-pyran

C19H17N3O (303.1371552)


   

tert-butyl 4-(1,3-benzoxazol-2-yl)piperazine-1-carboxylate

tert-butyl 4-(1,3-benzoxazol-2-yl)piperazine-1-carboxylate

C16H21N3O3 (303.1582836)


   

3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]decan-2-one

3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]decan-2-one

C18H25NO3 (303.18343400000003)


   

ETHYL 2-(2-[4-(TERT-BUTYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

ETHYL 2-(2-[4-(TERT-BUTYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

C17H21NO2S (303.12929260000004)


   

(1S,2R)-n-benzyl-2-amino-1,2-diphenylethanol

(1S,2R)-n-benzyl-2-amino-1,2-diphenylethanol

C21H21NO (303.1623056)


   

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)aniline

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)aniline

C13H17BF3NO3 (303.12535180000003)


   

1-Methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)piperazine

1-Methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)piperazine

C13H16F3N3O2 (303.1194552)


   

1-[2-[4-(chloromethyl)phenoxy]ethyl]azepane,hydrochloride

1-[2-[4-(chloromethyl)phenoxy]ethyl]azepane,hydrochloride

C15H23Cl2NO (303.1156608)


   

(3S,5R)-benzyl 3-hyd(3S,5R)-benzyl 3-hydroxy-5-(trifluoromethyl)piperidine-1-carboxylate

(3S,5R)-benzyl 3-hyd(3S,5R)-benzyl 3-hydroxy-5-(trifluoromethyl)piperidine-1-carboxylate

C14H16F3NO3 (303.1082222)


   

3-BENZYL-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOTHIOAMIDE

3-BENZYL-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOTHIOAMIDE

C15H17N3O2S (303.1041422)


   

1,6-Dihydro-4-hydroxy-1-(4-methoxyphenyl)-2-methyl-6-(oxo)nicotinic acid ethyl ester

1,6-Dihydro-4-hydroxy-1-(4-methoxyphenyl)-2-methyl-6-(oxo)nicotinic acid ethyl ester

C16H17NO5 (303.1106672)


   

4-[1-Methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]butanoic acid

4-[1-Methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]butanoic acid

C16H21N3O3 (303.1582836)


   
   

Diphenylpiperidin-4-ylmethanol hydrochloride

Diphenylpiperidin-4-ylmethanol hydrochloride

C18H22ClNO (303.13898320000004)


   

3-(3-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

3-(3-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

C17H13N5O (303.1120048)


   

ETHYL 4-(BENZYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLATE

ETHYL 4-(BENZYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLATE

C15H17N3O2S (303.1041422)


   

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethoxy)aniline

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethoxy)aniline

C13H17BF3NO3 (303.12535180000003)


   

2,5-Diethoxy-4-((4-methylphenyl)thio)aniline

2,5-Diethoxy-4-((4-methylphenyl)thio)aniline

C17H21NO2S (303.12929260000004)


   

2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

C13H17BF3NO3 (303.12535180000003)


   

1-(3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile

1-(3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile

C16H19BClNO2 (303.11972940000004)


   

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRIMIDIN-2-AMINE

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRIMIDIN-2-AMINE

C12H17BF3N3O2 (303.13658480000004)


   

Ibrutinib deacryloylpiperidine

Ibrutinib deacryloylpiperidine

C17H13N5O (303.1120048)


   

N,N-Diphenyl-4-methoxybenzamide

N,N-Diphenyl-4-methoxybenzamide

C20H17NO2 (303.1259222)


   

Aditoprim

Aditoprime

C15H21N5O2 (303.1695166)


C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

   

1-TERT-BUTYL 6-METHYL 3-FORMYL-1H-INDOLE-1,6-DICARBOXYLATE

1-TERT-BUTYL 6-METHYL 3-FORMYL-1H-INDOLE-1,6-DICARBOXYLATE

C16H17NO5 (303.1106672)


   

Pentaglycine

Gly-Gly-Gly-Gly-Gly-OH

C10H17N5O6 (303.1178782)


   

5-tert-Butyl-4-diethylaminomethyl-2-methyl-furan-3-carboxylic acid hydrochloride

5-tert-Butyl-4-diethylaminomethyl-2-methyl-furan-3-carboxylic acid hydrochloride

C15H26ClNO3 (303.1601116)


   

2-(2,2,2-Trifluoroethoxy)pyridine-3-boronic acid pinacol ester

2-(2,2,2-Trifluoroethoxy)pyridine-3-boronic acid pinacol ester

C13H17BF3NO3 (303.12535180000003)


   

4-Diphenylmethoxypiperidine hydrochloride

4-Diphenylmethoxypiperidine hydrochloride

C18H22ClNO (303.13898320000004)


   

4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.2]octane-1-carboxylic acid

4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.2]octane-1-carboxylic acid

C17H21NO4 (303.1470506)


   

butyl prop-2-enoate, prop-2-enamide, styrene

butyl prop-2-enoate, prop-2-enamide, styrene

C18H25NO3 (303.18343400000003)


   

Pumosetrag

Pumosetrag

C15H17N3O2S (303.1041422)


C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

N-[3-(1h-Benzimidazol-2-Yl)-1h-Pyrazol-4-Yl]benzamide

N-[3-(1h-Benzimidazol-2-Yl)-1h-Pyrazol-4-Yl]benzamide

C17H13N5O (303.1120048)


   

Sanfetrinem sodium

Sanfetrinem sodium

C14H18NNaO5 (303.1082618)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

N-(indol-3-ylacetyl)glutamine

N-(indol-3-ylacetyl)glutamine

C15H17N3O4 (303.1219002)


A N(2)-acylglutamine that has indol-3-ylacetyl as the acyl group.

   
   

nor-6alpha-Oxycodol

nor-6alpha-Oxycodol

C17H21NO4 (303.1470506)


   

N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine Oxide

N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine Oxide

C16H21N3O3 (303.1582836)


   

(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid

(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid

C12H21N3O6 (303.1430286)


   

4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

C16H21N3OS (303.14052560000005)


   
   

1-(4-Methoxyphenyl)-3-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)urea

1-(4-Methoxyphenyl)-3-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)urea

C15H17N3O2S (303.1041422)


   

7-(3,5-Dimethyl-1-pyrazolyl)-5-methyl-3-phenylpyrazolo[1,5-a]pyrimidine

7-(3,5-Dimethyl-1-pyrazolyl)-5-methyl-3-phenylpyrazolo[1,5-a]pyrimidine

C18H17N5 (303.1483882)


   

(1-Tert-butyl-5-phenyl-1h-pyrrol-3-yl)(phenyl)methanone

(1-Tert-butyl-5-phenyl-1h-pyrrol-3-yl)(phenyl)methanone

C21H21NO (303.1623056)


   
   

(3Z,5Z)-3,5-bis[(4-methylphenyl)methylidene]piperidin-4-one

(3Z,5Z)-3,5-bis[(4-methylphenyl)methylidene]piperidin-4-one

C21H21NO (303.1623056)


   

8-(2,5-Dimethoxy-benzyl)-2-fluoro-9H-purin-6-ylamine

8-(2,5-Dimethoxy-benzyl)-2-fluoro-9H-purin-6-ylamine

C14H14FN5O2 (303.1131476)


   

3-(4-Phenylamino-phenylamino)-2-(1H-tetrazol-5-YL)-acrylonitrile

3-(4-Phenylamino-phenylamino)-2-(1H-tetrazol-5-YL)-acrylonitrile

C16H13N7 (303.1232378)


   

Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine

Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine

C12H21N3O6 (303.1430286)


   

Retigabine

Retigabine

C16H18FN3O2 (303.138298)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators

   
   

(2S)-1-[(3S)-3-{[(3S)-3-ammonio-3-carboxylatopropyl]ammonio}-3-carboxylatopropyl]azetidinium-2-carboxylate

(2S)-1-[(3S)-3-{[(3S)-3-ammonio-3-carboxylatopropyl]ammonio}-3-carboxylatopropyl]azetidinium-2-carboxylate

C12H21N3O6 (303.1430286)


   

D-nopalinate(1-)

D-nopalinate(1-)

C11H19N4O6- (303.13045339999996)


Conjugate base of D-nopaline in which the three carboxy groups are anionic and the secondary amino and guanidino groups are cationic; major species at pH 7.3.

   

N6-[(Indole-3-yl)acetyl]-L-lysine

N6-[(Indole-3-yl)acetyl]-L-lysine

C16H21N3O3 (303.1582836)


   

Indol-3-ylacetylglutamine

Indol-3-ylacetylglutamine

C15H17N3O4 (303.1219002)


   

(2S)-1-[(3S)-3-carboxylato-3-[(3-carboxylato-3-hydroxypropyl)azaniumyl]propyl]azetidin-1-ium-2-carboxylate

(2S)-1-[(3S)-3-carboxylato-3-[(3-carboxylato-3-hydroxypropyl)azaniumyl]propyl]azetidin-1-ium-2-carboxylate

C12H19N2O7- (303.1192204)


   
   

1-[(3S)-3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid

1-[(3S)-3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid

C12H21N3O6 (303.1430286)


   
   

2-Ethylpentanedioylcarnitine

2-Ethylpentanedioylcarnitine

C14H25NO6 (303.168179)


   

2,2-dimethylpentanedioylcarnitine

2,2-dimethylpentanedioylcarnitine

C14H25NO6 (303.168179)


   

1-Oxononan-4-yl (2R)-2-acetamido-3-sulfanylpropanoate

1-Oxononan-4-yl (2R)-2-acetamido-3-sulfanylpropanoate

C14H25NO4S (303.15042100000005)


   

3-Methyladipoylcarnitine

3-Methyladipoylcarnitine

C14H25NO6 (303.168179)


   

(2E)-4-Hydroxy-3-methylpent-2-enedioylcarnitine

(2E)-4-Hydroxy-3-methylpent-2-enedioylcarnitine

C13H21NO7 (303.13179560000003)


   

Pipercallosidine

Pipercallosidine

C18H25NO3 (303.18343400000003)


An enamide that is (2E)-N-isobutylhept-2-enamide which is substituted at position 7 by a 3,4-methylenedioxyphenyl group. A natural product found in Piper sarmentosum.

   
   

N-hydroxy-7-(naphthalen-2-ylthio)heptanamide

N-hydroxy-7-(naphthalen-2-ylthio)heptanamide

C17H21NO2S (303.12929260000004)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   

Leu-Thr-Ala

Leu-Thr-Ala

C13H25N3O5 (303.179412)


A tripeptide composed of L-leucine, L-threonine and L-alanine joined in sequence by peptide linkages.

   

7-methyl-7,8-dihydro-6H-dichromeno[3,2-c:2,3-d]pyridine

7-methyl-7,8-dihydro-6H-dichromeno[3,2-c:2,3-d]pyridine

C20H17NO2 (303.1259222)


   

1-[[(1-Methyl-2-benzimidazolyl)amino]methyl]-2-naphthalenol

1-[[(1-Methyl-2-benzimidazolyl)amino]methyl]-2-naphthalenol

C19H17N3O (303.1371552)


   

2-[2-(Ethylthio)-1-benzimidazolyl]-1-(1-piperidinyl)ethanone

2-[2-(Ethylthio)-1-benzimidazolyl]-1-(1-piperidinyl)ethanone

C16H21N3OS (303.14052560000005)


   

1-(1-Adamantyl)-2-[(1-oxido-2-pyridin-1-iumyl)thio]ethanone

1-(1-Adamantyl)-2-[(1-oxido-2-pyridin-1-iumyl)thio]ethanone

C17H21NO2S (303.12929260000004)


   
   

[(4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

[(4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1470506)


   

3alpha,4alpha-Epoxy-5beta-pipermethystine

3alpha,4alpha-Epoxy-5beta-pipermethystine

C16H17NO5 (303.1106672)


   

Leu-Asp-Gly

Leu-Asp-Gly

C12H21N3O6 (303.1430286)


A tripeptide composed of L-leucine, L-aspartic acid and glycine joined in sequence by peptide linkages.

   
   
   
   

Glutamyl-valyl-glycine

Glutamyl-valyl-glycine

C12H21N3O6 (303.1430286)


   
   
   

diethyl 6-methyl-4-oxo-4H-quinolizine-1,3-dicarboxylate

diethyl 6-methyl-4-oxo-4H-quinolizine-1,3-dicarboxylate

C16H17NO5 (303.1106672)


   

4,6-Dimethyl-3-(3-naphthalen-1-yl-acryloyl)-1H-pyridin-2-one

4,6-Dimethyl-3-(3-naphthalen-1-yl-acryloyl)-1H-pyridin-2-one

C20H17NO2 (303.1259222)


   

5-(beta-D-glucosylmethyl)cytosine

5-(beta-D-glucosylmethyl)cytosine

C11H17N3O7 (303.1066452)


   

1-[[(1,3-Dimethyl-4-pyrazolyl)-oxomethyl]amino]-3-(4-methylphenyl)thiourea

1-[[(1,3-Dimethyl-4-pyrazolyl)-oxomethyl]amino]-3-(4-methylphenyl)thiourea

C14H17N5OS (303.1153752)


   

N-[1-[(4-chlorophenyl)methyl]-4-pyrazolyl]cyclopentanecarboxamide

N-[1-[(4-chlorophenyl)methyl]-4-pyrazolyl]cyclopentanecarboxamide

C16H18ClN3O (303.1138328)


   

8-methyl-N-[(4-methylphenyl)methyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

8-methyl-N-[(4-methylphenyl)methyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

C18H17N5 (303.1483882)


   

5-(3-Methylbutyl)-5-(2-pyridin-4-ylethyl)-1,3-diazinane-2,4,6-trione

5-(3-Methylbutyl)-5-(2-pyridin-4-ylethyl)-1,3-diazinane-2,4,6-trione

C16H21N3O3 (303.1582836)


   

5-[(3-Hydroxypropylamino)methylidene]-1-(phenylmethyl)-1,3-diazinane-2,4,6-trione

5-[(3-Hydroxypropylamino)methylidene]-1-(phenylmethyl)-1,3-diazinane-2,4,6-trione

C15H17N3O4 (303.1219002)


   

O-pimelylcarnitine

O-pimelylcarnitine

C14H25NO6 (303.168179)


An O-acylcarnitine in which the acyl group specified is pimelyl.

   

7-(4-Fluorophenyl)-5-methyl-3-phenylpyrazolo[1,5-a]pyrimidine

7-(4-Fluorophenyl)-5-methyl-3-phenylpyrazolo[1,5-a]pyrimidine

C19H14FN3 (303.1171696)


   

N-[(3,5-dimethoxyphenyl)methyl]-1-[4-(methylthio)phenyl]methanamine

N-[(3,5-dimethoxyphenyl)methyl]-1-[4-(methylthio)phenyl]methanamine

C17H21NO2S (303.12929260000004)


   

3-amino-2,6-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-one

3-amino-2,6-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-one

C17H13N5O (303.1120048)


   

3-hydroxy-7-methyl-2-[(1E,3E)-nona-1,3-dien-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione

3-hydroxy-7-methyl-2-[(1E,3E)-nona-1,3-dien-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione

C17H21NO4 (303.1470506)


   

3-(1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)-N-propan-2-ylpyrrolidine-1-carboxamide

3-(1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)-N-propan-2-ylpyrrolidine-1-carboxamide

C15H21N5O2 (303.1695166)


   

(4S)-4-(6-carboxyhexanoyloxy)-4-(trimethylazaniumyl)butanoate

(4S)-4-(6-carboxyhexanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.168179)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

6,8,10-Trimethylbenzo[4,5]cyclohepta[1,2-b]indole-9,11-diol

6,8,10-Trimethylbenzo[4,5]cyclohepta[1,2-b]indole-9,11-diol

C20H17NO2 (303.1259222)


   
   

[(2R,3R,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695166)


   

[(2R,3R,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695166)


   

[(2R,3S,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3S,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695166)


   

[(2S,3S,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695166)


   

N-[(Z)-1H-indol-3-ylmethylideneamino]-2-phenylcyclopropane-1-carboxamide

N-[(Z)-1H-indol-3-ylmethylideneamino]-2-phenylcyclopropane-1-carboxamide

C19H17N3O (303.1371552)


   

(R,R,R)-nicotianamine

(R,R,R)-nicotianamine

C12H21N3O6 (303.1430286)


   

(S,R,R)-nicotianamine

(S,R,R)-nicotianamine

C12H21N3O6 (303.1430286)


   

(R,S,S)-nicotianamine

(R,S,S)-nicotianamine

C12H21N3O6 (303.1430286)


   

Discadenine(1-)

Discadenine(1-)

C14H19N6O2- (303.1569414)


An L-alpha-amino-acid anion that is the conjugate base formed when discadenine (a 6-isopentenylaminopurine having a 3-amino-3-carboxypropyl group attached at the 3-position) is deprotonated.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(allyl 7-azido-3,7-dideoxy-beta-L-gulo-oct-2-ulopyranosid)onic acid

(allyl 7-azido-3,7-dideoxy-beta-L-gulo-oct-2-ulopyranosid)onic acid

C11H17N3O7 (303.1066452)


   

1-{(E)-2-(methylthio)-1-[2-(pentyloxy)phenyl]vinyl}-1H-imidazol-3-ium

1-{(E)-2-(methylthio)-1-[2-(pentyloxy)phenyl]vinyl}-1H-imidazol-3-ium

C17H23N2OS+ (303.1531008)


   

9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

C15H27O6- (303.1807542)


   

(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

C15H27O6- (303.1807542)


   

2-[(1S)-1,8-diethyl-6-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

2-[(1S)-1,8-diethyl-6-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

C17H21NO4 (303.1470506)


   

2-amino-3-methyl-4H-imidazol-5-one;2-(6-methoxy-1H-indol-3-yl)ethanamine

2-amino-3-methyl-4H-imidazol-5-one;2-(6-methoxy-1H-indol-3-yl)ethanamine

C15H21N5O2 (303.1695166)


   

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

C14H23O7- (303.1443708)


   

propan-2-yl 3a,8b-dihydroxy-2-methyl-4-oxo-3H-indeno[1,2-b]pyrrole-3-carboxylate

propan-2-yl 3a,8b-dihydroxy-2-methyl-4-oxo-3H-indeno[1,2-b]pyrrole-3-carboxylate

C16H17NO5 (303.1106672)


   

8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

C14H23O7- (303.1443708)


   

2-[(1S)-1-ethyl-8-(2-hydroxyethyl)-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

2-[(1S)-1-ethyl-8-(2-hydroxyethyl)-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

C17H21NO4 (303.1470506)


   

2-[(1S)-1,8-diethyl-7-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

2-[(1S)-1,8-diethyl-7-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

C17H21NO4 (303.1470506)


   

Sdccgsbi-0051046.P002

Sdccgsbi-0051046.P002

C17H21NO4 (303.1470506)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

[(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2R)-3-hydroxy-2-phenylpropanoate

[(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2R)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1470506)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives

   

tetra(methoxymethyl)melamine (putative)

tetra(methoxymethyl)melamine (putative)

C11H23N6O4+ (303.1780698)


   

1-Butyl-5-hydroxy-3-methoxycarbonyl-2,4,6,7-tetramethylindole

1-Butyl-5-hydroxy-3-methoxycarbonyl-2,4,6,7-tetramethylindole

C18H25NO3 (303.18343400000003)


   

2-(2-Hydroxyethoxy)-N-(2-(dimethylamino)ethyl)-4-qutnolinecarboxamide

2-(2-Hydroxyethoxy)-N-(2-(dimethylamino)ethyl)-4-qutnolinecarboxamide

C16H21N3O3 (303.1582836)


   

FENAMIPHOS

FENAMIPHOS

C13H22NO3PS (303.10579520000005)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D016573 - Agrochemicals D010575 - Pesticides

   

N(6)-[(indol-3-yl)acetyl]-L-lysine

N(6)-[(indol-3-yl)acetyl]-L-lysine

C16H21N3O3 (303.1582836)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   
   

D-23129

N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester

C16H18FN3O2 (303.138298)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators Same as: D09569

   

Aptiganel

Aptiganel

C20H21N3 (303.17353860000003)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   
   

O-pimelyl-L-carnitine

O-pimelyl-L-carnitine

C14H25NO6 (303.168179)


An O-acyl-L-carnitine that is L-carnitine having a pimelyl group as the acyl substituent.

   
   
   

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

C12H21N3O6 (303.1430286)


   

O-Pimeloylcarnitine

O-Pimeloylcarnitine

C14H25NO6 (303.168179)


An O-acylcarnitine having pimeloyl as the acyl substituent.

   

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

C12H21N3O6 (303.1430286)


   

oscr#10(1-)

oscr#10(1-)

C15H27O6 (303.1807542)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#10, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#10(1-)

ascr#10(1-)

C15H27O6 (303.1807542)


A monocarboxylic acid anion resulting from the deprotonation of the carboxy group of ascr#10. The conjugate base of ascr#10 and the major species at pH 7.3.

   

(S,S,S)-nicotianamine trizwitterion

(S,S,S)-nicotianamine trizwitterion

C12H21N3O6 (303.1430286)


An amino acid zwitterion resulting from transfer of three protons from the carboxy to the amino groups of (S,S,S)-nicotianamine. One of two major microspecies at physiological pH.

   

N(6)-[(indol-3-yl)acetyl]-L-lysine zwitterion

N(6)-[(indol-3-yl)acetyl]-L-lysine zwitterion

C16H21N3O3 (303.1582836)


Zwitterionic form of N(6)-[(indol-3-yl)acetyl]-L-lysine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

pyranonigrin K

pyranonigrin K

C17H21NO4 (303.1470506)


A member of the class of pyranopyrroles with formula C17H21NO4, originally isolated from Aspergillus niger.

   
   
   
   

N(6)-[(Indol-3-yl)acetyl]-lysine

N(6)-[(Indol-3-yl)acetyl]-lysine

C16H21N3O3 (303.1582836)


   
   
   
   

(5s)-5,8,9-trimethoxy-2,10-dimethyl-4h,5h-pyrano[2,3-b]quinoline

(5s)-5,8,9-trimethoxy-2,10-dimethyl-4h,5h-pyrano[2,3-b]quinoline

C17H21NO4 (303.1470506)


   

(1r,5r,6r,7r,9s,11s,12s,13s,14s)-3-imino-14-methyl-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

(1r,5r,6r,7r,9s,11s,12s,13s,14s)-3-imino-14-methyl-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O7 (303.1066452)


   

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

C17H21NO4 (303.1470506)


   

(1s,10s,12s,15r)-4,12-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,15-diol

(1s,10s,12s,15r)-4,12-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,15-diol

C17H21NO4 (303.1470506)


   

(13s)-13-(2-hydroxypropan-2-yl)-16-methyl-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

(13s)-13-(2-hydroxypropan-2-yl)-16-methyl-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

C16H17NO5 (303.1106672)


   

(2s,3r,4s,6s)-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

(2s,3r,4s,6s)-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

C17H21NO4 (303.1470506)


   

3-imino-14-methyl-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

3-imino-14-methyl-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1⁷,¹¹.0¹,⁶]tetradecane-5,9,12,13,14-pentol

C11H17N3O7 (303.1066452)


   

4-(5,7-dihydroxy-2-methyl-4-oxochromen-6-yl)-1-methylpiperidin-2-one

4-(5,7-dihydroxy-2-methyl-4-oxochromen-6-yl)-1-methylpiperidin-2-one

C16H17NO5 (303.1106672)


   

5,8,12,13-tetrahydroxy-8-(hydroxymethyl)-3-imino-10-oxa-2,4-diazatricyclo[7.3.1.0¹,⁶]tridecan-11-one

5,8,12,13-tetrahydroxy-8-(hydroxymethyl)-3-imino-10-oxa-2,4-diazatricyclo[7.3.1.0¹,⁶]tridecan-11-one

C11H17N3O7 (303.1066452)


   

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-13,16,17-triol

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-13,16,17-triol

C16H17NO5 (303.1106672)


   

(1s,2r,4s,5s,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

(1s,2r,4s,5s,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1470506)


   

(1s,14r,15s,16s)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-14,15-diol

(1s,14r,15s,16s)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-14,15-diol

C17H21NO4 (303.1470506)


   

(1s,2r,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

(1s,2r,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

C17H21NO4 (303.1470506)


   

5-({[2-hydroxy-2-(4-hydroxyphenyl)ethyl](methyl)amino}methyl)-2-methoxyphenol

5-({[2-hydroxy-2-(4-hydroxyphenyl)ethyl](methyl)amino}methyl)-2-methoxyphenol

C17H21NO4 (303.1470506)


   

(1r,2r,12s,14s)-9-methoxy-3-methyl-11-oxa-3-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

(1r,2r,12s,14s)-9-methoxy-3-methyl-11-oxa-3-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

C17H21NO4 (303.1470506)


   

2-methyl-10-{[(1e)-2-phenylethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

2-methyl-10-{[(1e)-2-phenylethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C19H17N3O (303.1371552)


   

5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

C17H21NO4 (303.1470506)


   

6-[(1r,2s,4ar,6r,8ar)-6-hydroxy-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

6-[(1r,2s,4ar,6r,8ar)-6-hydroxy-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

C17H21NO4 (303.1470506)


   

2-amino-4-[(4-carbamimidamido-1-carboxybutyl)-c-hydroxycarbonimidoyl]butanoic acid

2-amino-4-[(4-carbamimidamido-1-carboxybutyl)-c-hydroxycarbonimidoyl]butanoic acid

C11H21N5O5 (303.15426160000004)